Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Patients With Philadelphia Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

NCT02783651 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02783651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02783651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Patients With Philadelphia Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
June 30, 2016
Completion date
March 31, 2020
Enrollment
212 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory acute lymphoblastic leukemia